Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds JP Morgan Downgrades Offerpad Solutions to Neutral

JP Morgan Downgrades Offerpad Solutions to Neutral

JP Morgan analyst Dae Lee downgrades Offerpad Solutions (NYSE:OPAD) from Overweight to Neutral.

byBenzinga Newsdesk

March 8, 2023

1 minute read

JP Morgan analyst Dae Lee downgrades Offerpad Solutions (NYSE:OPAD) from Overweight to Neutral.

Movers
News

What’s Going On With Mustang Bio Stock Tuesday?

By Dylan Berman

June 18, 11:34 AM

Mustang Bio announced Monday safety and efficacy data from its Phase 1/2 clinical trial of MB-106, a possible treatment for certain types of blood cancer.

MBIO

Benzinga’s Top Ratings Upgrades, Downgrades For December 28, 2022

By Benzinga Insights

December 28, 11:00 AM

Upgrades See all analyst ratings upgrades. Downgrades See all analyst ratings downgrades. Initiations Capital One initiated coverage on…

AKLI

Biohaven Pharmaceutical Q3 EPS $(1.75) Up From $(1.91) YoY

By Bill Haddad

November 9, 8:18 AM

Biohaven Pharmaceutical (NYSE:BHVN) reported quarterly losses of $(1.75) per share. This is a 8.38 percent increase over losses of $(1.91) per share from the same period last year.

BHVN